Cafepharma Today

June 27 2025 - ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
ACIP skips votes on COVID and Moderna’s mRESVIA but scrutinzes mRNA vaccine safety
VC legal dispute threatens biotech startups
Multiple sclerosis market expected to reach $25.9bn across the 7MM by 2034
Novo Nordisk Foundation gives $75m for R&D 'challenges'
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ozempic on Wall Street's list for 2027 Medicare drug negotiations
Reuters
Friday, August 23, 2024 - 10:59am
tags:
Ozempic, Novo Nordisk, Pfizer, GSK, Medicare, drug pricing
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Fierce Biotech
Friday, August 23, 2024 - 10:57am
tags:
Bicara Therapeutics, Zenas BioPharma, IPOs
FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds
Fierce Pharma
Friday, August 23, 2024 - 10:55am
tags:
FDA, stomach cancer, Bristol Myers Squibb, Opdivo, Yervoy, Merck, Keytruda, BeiGene, Tevimbra
FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial
Clinical Trials Arena
Friday, August 23, 2024 - 10:49am
tags:
Galapagos, non-Hodgkin lymphoma, clinical trials, GLPG5101
Walgreens Is Reportedly Considering a Drastic Move to Improve Its Cash Flow
Motley Fool
Friday, August 23, 2024 - 10:46am
tags:
Walgreens, pharmacies, VillageMD
AstraZeneca dismisses rumors of facility relocation to US
Pharmaphorum
Friday, August 23, 2024 - 10:44am
tags:
AstraZeneca, UK, vaccines, drug manufacturing
Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
Clinical Trials Arena
Friday, August 23, 2024 - 10:42am
tags:
Jazz Pharma, Cannabidiol, Japan, Epidiolex
Updated COVID shots from Pfizer, Moderna cleared by FDA
BioPharma Dive
Thursday, August 22, 2024 - 10:03pm
tags:
COVID-19, vaccines, Pfizer, Moderna Therapeutics, FDA
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO
Reuters
Thursday, August 22, 2024 - 10:01pm
tags:
Zenas BioPharma, IPOs, Bristol Myers Squibb
Gilead’s Livdelzi (Seladelpar) for Primary Biliary Cholangitis Promises Pruritus Reduction
Xtalks
Thursday, August 22, 2024 - 10:00pm
tags:
FDA, Livdelzi, Gilead Sciences, primary biliary cholangitis
AstraZeneca warns of shifting UK vaccine production to US, FT reports
Reuters
Thursday, August 22, 2024 - 9:57pm
tags:
AstraZeneca, vaccines, UK
A First for Hypoparathyroidism — Yorvipath (Palopegteriparatide) Earns FDA Nod
Xtalks
Thursday, August 22, 2024 - 9:51pm
tags:
Yorvipath, FDA, hypoparathyroidism, Ascendis Pharma
Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push
Fierce Biotech
Thursday, August 22, 2024 - 11:55am
tags:
Eli Lilly, Oblique Therapeutics, AbiProt, drug discovery, antibodies
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thursday, August 22, 2024 - 11:45am
tags:
Eisai, Biogen, Leqembi, UK, Alzheimer's disease
Updated COVID vaccines are coming soon
NPR
Thursday, August 22, 2024 - 11:20am
tags:
FDA, COVID-19, vaccines
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Fierce Biotech
Thursday, August 22, 2024 - 11:18am
tags:
Novartis, Chinook Therapeutics, kidney disease, venture capital, Versant Ventures
First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1
Biopharma Reporter
Thursday, August 22, 2024 - 11:15am
tags:
ImmPACT Bio, CAR-T, MS, multiple sclerosis, FDA, clinical trials
Musk's Neuralink says second trial implant went well, no thread retraction issue
Reuters
Thursday, August 22, 2024 - 11:12am
tags:
Neuralink, Elon Musk, brain implants, clinical trials
First real-world analysis of Merck's Ebola vaccine reveals 84% efficacy during DRC outbreak
Fierce Pharma
Thursday, August 22, 2024 - 11:11am
tags:
Merck, vaccines, ebola virus
Will the IRA squash new drugs? Those worries are likely exaggerated, studies say.
Pharma Voice
Thursday, August 22, 2024 - 11:10am
tags:
innovation, drug development, R&D, Inflation Reduction Act

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.